INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.४२
arrow_downward
-०.७०%(-०.०१००) 1D
नोभेम्बर १६, १४:४७:२० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.४२
High
US$ १.४८
Low
US$ १.३७
Mkt. cap
२६.६० करोड
Avg. vol.
१.९३ करोड
Volume
४४.८७ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ ०.८०
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
Open
US$ १.४२
High
US$ १.४८
Low
US$ १.३७
Mkt. cap
२६.६० करोड
Avg. vol.
१.९३ करोड
Volume
४४.८७ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ ०.८०
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
News stories
From web sources and news partners
Investor's Business Daily
·
३६ मिनेट पहिले
Tyson, Starbucks Lead The S&P 500, Nasdaq 100 As Investors Play Defense
The Motley Fool
·
१ घण्टा पहिले
McDonald's Is Underperforming the S&P 500 and Nasdaq-100. Could January Mark a Turning Point?
Yahoo Finance
·
२८ मिनेट पहिले
The S&P 500’s shot at 4 straight double-digit years is in Nvidia’s hands
The Korea Times
·
१ घण्टा पहिले
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc